Get the Stockscreener App
5.27
2.53%
0.13
Vir Biotechnology Inc stock is traded at $5.27, with a volume of 1.02M.
It is up +2.53% in the last 24 hours and up +3.13% over the past month.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
See More
Previous Close:
$5.14
Open:
$5.17
24h Volume:
1.02M
Relative Volume:
0.80
Market Cap:
$732.09M
Revenue:
$62.04M
Net Income/Loss:
$-533.34M
P/E Ratio:
-1.3444
EPS:
-3.92
Net Cash Flow:
$-473.07M
1W Performance:
+6.68%
1M Performance:
+3.13%
6M Performance:
-35.89%
1Y Performance:
-31.11%
1-Day Range:
$5.095
$5.3381
1-Week Range:
$4.87
$5.638
52-Week Range:
$4.155
$14.45
Vir Biotechnology Inc Stock (VIR) Company Profile
Name
Vir Biotechnology Inc
Sector
Industry
Phone
415-906-4324
Address
1800 OWENS STREET, SAN FRANCISCO, CA
Compare VIR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VIR
Vir Biotechnology Inc
|
5.27 | 714.03M | 62.04M | -533.34M | -473.07M | -3.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Vir Biotechnology Inc Stock (VIR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Initiated | Evercore ISI | Outperform |
| Aug-27-25 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-29-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-08-23 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-06-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-21-23 | Upgrade | Goldman | Neutral → Buy |
| Jan-27-23 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Sep-14-22 | Initiated | SVB Leerink | Outperform |
| Sep-09-22 | Initiated | Morgan Stanley | Underweight |
| Mar-03-22 | Upgrade | Robert W. Baird | Underperform → Neutral |
| Dec-21-21 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Oct-25-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-22-21 | Downgrade | Goldman | Buy → Neutral |
| Jun-04-21 | Resumed | Robert W. Baird | Neutral |
| Jan-27-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-20-21 | Reiterated | H.C. Wainwright | Buy |
| Oct-05-20 | Initiated | BofA Securities | Buy |
| Sep-14-20 | Upgrade | Goldman | Neutral → Buy |
| Sep-11-20 | Upgrade | JP Morgan | Underweight → Neutral |
| Aug-20-20 | Initiated | Needham | Buy |
| Mar-19-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-13-20 | Downgrade | Goldman | Buy → Neutral |
| Feb-27-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Feb-04-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-14-19 | Initiated | Robert W. Baird | Neutral |
| Nov-05-19 | Initiated | Barclays | Overweight |
| Nov-05-19 | Initiated | Cowen | Outperform |
| Nov-05-19 | Initiated | Goldman | Buy |
| Nov-05-19 | Initiated | JP Morgan | Overweight |
View All
Vir Biotechnology Inc Stock (VIR) Latest News
Vir Biotechnology Inc. stock momentum explainedMarket Activity Report & AI Driven Stock Reports - Newser
Real time social sentiment graph for Vir Biotechnology Inc.Quarterly Earnings Summary & Verified Momentum Stock Ideas - Newser
Using fundamentals and technicals on Vir Biotechnology Inc.Earnings Performance Report & Accurate Buy Signal Notifications - Newser
What is Vir Biotechnology Inc. s revenue forecastJuly 2025 Pullbacks & Low Risk Entry Point Guides - 강소기업뉴스
How to integrate Vir Biotechnology Inc. into portfolio analysis toolsJuly 2025 Big Picture & Accurate Intraday Trading Signals - Newser
Technical signs of recovery in Vir Biotechnology Inc.Weekly Stock Report & Weekly Breakout Opportunity Watchlist - Newser
Analyzing net buyer seller activity in Vir Biotechnology Inc.Market Risk Analysis & Free Low Drawdown Momentum Trade Ideas - Newser
Forecasting Vir Biotechnology Inc. price range with options dataJuly 2025 Pullbacks & Low Volatility Stock Suggestions - Newser
Vir Biotechnology Inc. stock prediction for this weekCEO Change & AI Based Buy and Sell Signals - Newser
Is Vir Biotechnology Inc. subject to activist investor interestMarket Rally & Growth Focused Entry Reports - خودرو بانک
What are Vir Biotechnology Inc.’s growth levers2025 Pullback Review & Weekly High Potential Stock Alerts - خودرو بانک
Trend analysis for Vir Biotechnology Inc. this weekJuly 2025 Closing Moves & Technical Pattern Based Buy Signals - Newser
Why Vir Biotechnology Inc. stock attracts strong analyst attentionWeekly Market Report & Advanced Swing Trade Entry Plans - Newser
What earnings revisions data tells us about Vir Biotechnology Inc.July 2025 Short Interest & Weekly Breakout Opportunity Watchlist - Newser
Can Vir Biotechnology Inc. recover in the next quarterTrade Volume Summary & Daily Stock Trend Watchlist - Newser
Vir Biotechnology Inc. stock outlook for YEAR2025 Market Sentiment & Weekly Stock Breakout Alerts - Newser
Using data tools to time your Vir Biotechnology Inc. exitJuly 2025 PreEarnings & Weekly Breakout Opportunity Watchlist - Newser
Earnings Update: What is Vir Biotechnology Inc. s revenue forecastRecession Risk & Free Fast Gain Swing Trade Alerts - خودرو بانک
Vir Biotechnology's Sharp Intraday Drop: What's Behind the Move? - AInvest
Is it time to cut losses on Vir Biotechnology Inc.Portfolio Risk Summary & Real-Time Market Trend Scan - Newser
Using Bollinger Bands to evaluate Vir Biotechnology Inc.2025 Short Interest & Real-Time Volume Trigger Notifications - Newser
Historical volatility pattern of Vir Biotechnology Inc. visualizedTrade Performance Summary & Low Volatility Stock Suggestions - Newser
Vir Biotechnology: A Contrarian Buy in a High-Risk, High-Reward Biotech Play - AInvest
The Play On Vir Biotechnology (NASDAQ:VIR) - Seeking Alpha
Sato Vicki L, Vir Biotechnology director, sells $109k in shares - Investing.com Canada
Vir Biotechnology (VIR.O) Surges 7.3%—What’s Behind the Intraday Move? - AInvest
Vir Biotechnology Director Sells 22K Shares at $4.99 on 2025-09-02. - AInvest
Vir Biotechnology Surges 5.1% — But No Technical Signals Fired — Here’s What Could Be Behind It - AInvest
Should you wait for a breakout in Vir Biotechnology Inc.Market Weekly Review & Verified Chart Pattern Trade Signals - Newser
Analyzing recovery setups for Vir Biotechnology Inc. investors2025 Market Sentiment & Smart Investment Allocation Tips - Newser
What are the analyst revisions for Vir Biotechnology Inc.Is LBTYB stock a good investment in YEAR2025 Top Gainers & Weekly High Conviction Trade Ideas - خودرو بانک
Evercore ISI initiates coverage on Vir Biotechnology with Outperform rating, $12 PT. - AInvest
Evercore ISI initiates Vir Biotechnology stock with Outperform rating - Investing.com
How sentiment analysis helps forecast Vir Biotechnology Inc.Weekly Profit Summary & Real-Time Buy Signal Notifications - Newser
Hedge Fund Bets: Will Vir Biotechnology Inc. outperform the market in YEARMarket Performance Report & Low Drawdown Investment Ideas - خودرو بانک
What to expect from Vir Biotechnology Inc. in the next 30 daysPortfolio Update Summary & Proven Capital Preservation Methods - Newser
Heatmap analysis for Vir Biotechnology Inc. and competitorsMarket Risk Analysis & Free Low Drawdown Momentum Trade Ideas - Newser
What MACD signals say about Vir Biotechnology Inc.Dip Buying & AI Enhanced Trading Alerts - Newser
Does Vir Biotechnology Inc. stock benefit from AI growthJuly 2025 Movers & Fast Gaining Stock Strategy Reports - خودرو بانک
Vir Biotechnology Inc Stock (VIR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):